U
XTL Biopharmaceuticals Ltd. XTLB
$1.45 $0.129.02% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 12/31/2023 09/30/2023 06/30/2023 03/31/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -- -13.65% -16.68% -10.83% -17.48%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -- -13.07% -16.05% -10.98% -15.84%
Operating Income -- 13.07% 16.05% 10.98% 15.84%
Income Before Tax -- -32.20% -250.23% -287.51% -522.71%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -- -32.20% -250.23% -287.51% -522.71%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -- -32.20% -250.23% -287.51% -522.71%
EBIT -- 13.07% 16.05% 10.98% 15.84%
EBITDA -- 13.08% 16.06% 10.99% 15.85%
EPS Basic -- -32.00% -255.56% -296.30% -610.00%
Normalized Basic EPS -- -300.00% -107.14% -107.14% -91.67%
EPS Diluted -- -44.00% -438.46% -507.69% -1,175.00%
Normalized Diluted EPS -- -300.00% -110.53% -110.53% -66.67%
Average Basic Shares Outstanding -- 0.00% 0.01% 0.34% 1.13%
Average Diluted Shares Outstanding -- 0.00% -13.29% -13.04% -12.44%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --